K2 HealthVentures Provides $50MM Credit Facility to Mind Medicine
Mind Medicine, a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, entered into a senior secured credit facility with K2 HealthVentures, a healthcare-focused specialty finance company.
August 15, 2023
Austin Sherwindt | K2 HealthVentures | Mind Medicine | Robert Barrow
Ian Koplin